Matches in SemOpenAlex for { <https://semopenalex.org/work/W3015165699> ?p ?o ?g. }
- W3015165699 abstract "Abstract Atherosclerosis development leads to irreversible cascades, highlighting the unmet need for improved methods of early diagnosis and prevention. Disturbed flow formation is one of the earliest atherogenic events, resulting in increased endothelial permeability and subsequent monocyte recruitment. Here, a mesenchymal stem cell (MSC)‐derived nanovesicle (NV) that can target disturbed flow sites with the peptide GSPREYTSYMPH (PREY) (PMSC‐NVs) is presented which is selected through phage display screening of a hundred million peptides. The PMSC‐NVs are effectively produced from human MSCs (hMSCs) using plasmid DNA designed to functionalize the cell membrane with PREY. The potent anti‐inflammatory and pro‐endothelial recovery effects are confirmed, similar to those of hMSCs, employing mouse and porcine partial carotid artery ligation models as well as a microfluidic disturbed flow model with human carotid artery‐derived endothelial cells. This nanoscale platform is expected to contribute to the development of new theragnostic strategies for preventing the progression of atherosclerosis." @default.
- W3015165699 created "2020-04-10" @default.
- W3015165699 creator A5008731225 @default.
- W3015165699 creator A5009464340 @default.
- W3015165699 creator A5011179489 @default.
- W3015165699 creator A5012140745 @default.
- W3015165699 creator A5017707435 @default.
- W3015165699 creator A5020997539 @default.
- W3015165699 creator A5021009010 @default.
- W3015165699 creator A5033098563 @default.
- W3015165699 creator A5044594496 @default.
- W3015165699 creator A5049716945 @default.
- W3015165699 creator A5058387827 @default.
- W3015165699 creator A5063194236 @default.
- W3015165699 creator A5063281043 @default.
- W3015165699 creator A5065731981 @default.
- W3015165699 creator A5069869461 @default.
- W3015165699 creator A5070374265 @default.
- W3015165699 creator A5073894582 @default.
- W3015165699 creator A5081382387 @default.
- W3015165699 creator A5083846976 @default.
- W3015165699 date "2020-04-01" @default.
- W3015165699 modified "2023-09-27" @default.
- W3015165699 title "Anti‐Atherogenic Effect of Stem Cell Nanovesicles Targeting Disturbed Flow Sites" @default.
- W3015165699 cites W1806636020 @default.
- W3015165699 cites W1967296654 @default.
- W3015165699 cites W196835504 @default.
- W3015165699 cites W1968567802 @default.
- W3015165699 cites W1968928247 @default.
- W3015165699 cites W1969929083 @default.
- W3015165699 cites W1971218073 @default.
- W3015165699 cites W1976408796 @default.
- W3015165699 cites W1977657173 @default.
- W3015165699 cites W1986147205 @default.
- W3015165699 cites W1989531806 @default.
- W3015165699 cites W1995316729 @default.
- W3015165699 cites W1995344483 @default.
- W3015165699 cites W1996630410 @default.
- W3015165699 cites W2002822412 @default.
- W3015165699 cites W2011508825 @default.
- W3015165699 cites W2015230474 @default.
- W3015165699 cites W2020438602 @default.
- W3015165699 cites W2025395254 @default.
- W3015165699 cites W2026581189 @default.
- W3015165699 cites W2038399651 @default.
- W3015165699 cites W2040635479 @default.
- W3015165699 cites W2051720243 @default.
- W3015165699 cites W2093212994 @default.
- W3015165699 cites W2093279360 @default.
- W3015165699 cites W2099369804 @default.
- W3015165699 cites W2107008239 @default.
- W3015165699 cites W2108473914 @default.
- W3015165699 cites W2108853001 @default.
- W3015165699 cites W2111260632 @default.
- W3015165699 cites W2112540241 @default.
- W3015165699 cites W2119043140 @default.
- W3015165699 cites W2122710833 @default.
- W3015165699 cites W2132869487 @default.
- W3015165699 cites W2134161094 @default.
- W3015165699 cites W2141868068 @default.
- W3015165699 cites W2145790583 @default.
- W3015165699 cites W2149131980 @default.
- W3015165699 cites W2160718001 @default.
- W3015165699 cites W2163221788 @default.
- W3015165699 cites W2164840475 @default.
- W3015165699 cites W2171326612 @default.
- W3015165699 cites W2191284640 @default.
- W3015165699 cites W2275204317 @default.
- W3015165699 cites W2280289381 @default.
- W3015165699 cites W2475254585 @default.
- W3015165699 cites W2513318501 @default.
- W3015165699 cites W2578061423 @default.
- W3015165699 cites W2615669773 @default.
- W3015165699 cites W2623081681 @default.
- W3015165699 cites W2731656009 @default.
- W3015165699 cites W2745331910 @default.
- W3015165699 cites W2784423079 @default.
- W3015165699 cites W2888664067 @default.
- W3015165699 cites W2898593551 @default.
- W3015165699 cites W2914529686 @default.
- W3015165699 doi "https://doi.org/10.1002/smll.202000012" @default.
- W3015165699 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32239653" @default.
- W3015165699 hasPublicationYear "2020" @default.
- W3015165699 type Work @default.
- W3015165699 sameAs 3015165699 @default.
- W3015165699 citedByCount "13" @default.
- W3015165699 countsByYear W30151656992021 @default.
- W3015165699 countsByYear W30151656992022 @default.
- W3015165699 countsByYear W30151656992023 @default.
- W3015165699 crossrefType "journal-article" @default.
- W3015165699 hasAuthorship W3015165699A5008731225 @default.
- W3015165699 hasAuthorship W3015165699A5009464340 @default.
- W3015165699 hasAuthorship W3015165699A5011179489 @default.
- W3015165699 hasAuthorship W3015165699A5012140745 @default.
- W3015165699 hasAuthorship W3015165699A5017707435 @default.
- W3015165699 hasAuthorship W3015165699A5020997539 @default.
- W3015165699 hasAuthorship W3015165699A5021009010 @default.
- W3015165699 hasAuthorship W3015165699A5033098563 @default.
- W3015165699 hasAuthorship W3015165699A5044594496 @default.
- W3015165699 hasAuthorship W3015165699A5049716945 @default.